Ocugen (OCGN) Cash from Operations (2014 - 2026)
Ocugen (OCGN) posted Cash from Operations of 21794000.0 for Q1 2026, down 56.11% on a QoQ basis from 13961000.0 in Q4 2025, and down 12.59% year-over-year from 24933005.79 in Q1 2025.
Ocugen (OCGN) Cash from Operations (2014 - 2026) Analysis & Trends
Ocugen's Cash from Operations history runs 13 years deep, the most recent figure standing at 21794000.0 for Q1 2026.
- Quarterly Cash from Operations fell 12.59% year-over-year to 21794000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 59401000.0 (down 16.69% YoY) and the FY2025 annual result came in at 56964000.0, down 35.17% from the prior year.
- Cash from Operations was 21794000.0 for Q1 2026 at Ocugen, down from 13961000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 9911000.0 in Q2 2024 and bottomed at 21794000.0 in Q1 2026.
- A 5-year average of 14296058.82 and a median of 13797000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 185.18% — and 2024, when it surged 47.3%.
- Ocugen's Cash from Operations stood at 16914000.0 in 2022, then soared by 33.18% to 11302000.0 in 2023, then gained by 8.3% to 10364000.0 in 2024, then sank by 34.71% to 13961000.0 in 2025, then plunged by 56.11% to 21794000.0 in 2026.
- Business Quant data shows OCGN's Cash from Operations at 21794000.0 in Q1 2026, 13961000.0 in Q4 2025, and 12916000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | -21.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.79 Mn |
| Mar 31, 2026 | -21.79 Mn |
| Dec 31, 2025 | -13.96 Mn |
| Dec 31, 2025 | -13.96 Mn |
| Sep 30, 2025 | -12.92 Mn |
| Sep 30, 2025 | -12.92 Mn |
| Jun 30, 2025 | -10.73 Mn |
| Jun 30, 2025 | -10.73 Mn |
| Mar 31, 2025 | -19.36 Mn |
| Mar 31, 2025 | -19.36 Mn |
| Dec 31, 2024 | -10.36 Mn |
| Dec 31, 2024 | -10.36 Mn |
| Sep 30, 2024 | -11.27 Mn |
| Sep 30, 2024 | -11.27 Mn |
| Jun 30, 2024 | -9.91 Mn |
| Jun 30, 2024 | -9.91 Mn |
| Mar 31, 2024 | -10.60 Mn |
| Mar 31, 2024 | -10.60 Mn |
| Dec 31, 2023 | -11.30 Mn |
| Dec 31, 2023 | -11.30 Mn |